Skip to main content

Research News

  • NUS scientists discover novel approach to rejuvenate aged egg cells

    Researchers from the Mechanobiology Institute at NUS and the NUS Bia-Echo Asia Centre for Reproductive Longevity and Equality , based at the NUS Yong Loo Lin School of Medicine, have developed an innovative technique to significantly enhance the reproductive potential of aged oocytes, or immature egg cells, potentially paving the way for better outcomes of assisted reproductive technologies, such as in-vitro fertilisation , for older females.
  • Alopexx Announces Collaboration with Bharat Biotech for the Development and Commercialization of Broad-Spectrum Anti-Microbial Vaccine AV0328
    Alopexx, Inc., a clinical-stage biotechnology company focused on developing novel, broad-spectrum immune-mediated therapeutics for the prevention and treatment of bacterial, fungal, and parasitic infections, announced a collaboration with Bharat Biotech for the co-development and commercialization of Alopexxs proprietary broad-spectrum anti-microbial vaccine, AV0328, in India and other low income and lower middle-income countries.
  • Newly Discovered Antimicrobial Could Prevent or Treat Cholera

    More than a million people each year die from infections by pathogens that are resistant to antimicrobials, and the problem is growing. Meanwhile, the discovery of new antimicrobials that can help stem the tide has not kept pace.

  • Sex hormones modulate the immune system to influence disease risk differently

    Researchers have uncovered how hormones profoundly affect our immune systems, explaining why men and women are affected by diseases differently. 

    Scientists from the Karolinska Institutet in Sweden and Imperial College London have shown for the first time which aspects of our immune systems are regulated by sex hormones, and the impacts this has on disease risk and health outcomes in males and females.

  • Cognitive behavioral therapy enhances brain circuits to relieve depression

    A new study led by Stanford Medicine scientists found that certain changes in neural activity predicted which patients would benefit from a type of cognitive behavioral therapy.

    Cognitive behavioral therapy, one of the most common treatments for depression, can teach skills for coping with everyday troubles, reinforce healthy behaviors and counter negative thoughts. But can altering thoughts and behaviors lead to lasting changes in the brain?

  • GSK announces positive results from phase III trial of Nucala (mepolizumab) in COPD
    GSK plc announced positive headline results of MATINEE, the phase III clinical trial evaluating Nucala mepolizumab, a monoclonal antibody that targets interleukin-5 in adults with chronic obstructive pulmonary disease.
  • Mechanisms of how morphine relieves pain mapped out

    In a study published in Science, researchers at Karolinska Institutet describe the neural processes behind how morphine relieves pain. This is valuable knowledge because the drug has such serious side effects. 

    Morphine is a powerful painkiller that belongs to the group of opioids. It blocks signals in the pain pathways and also increases feelings of pleasure.  Morphine acts on several central and peripheral pain pathways in the body, but the neural processes behind the pain relief have not previously been fully understood.  

  • New findings on TB could change how we treat inflammatory disorders
    Tuberculosis is a confounding scourge. Its the leading cause of death from infectious disease in the world, and yet its estimated that those deaths represent perhaps 5% of infections with Mycobacterium tuberculosis.
  • Gut Bacteria Composition Influences Rotavirus Vaccine Efficacy

    Certain types of gut bacteria can hinder the efficacy of the rotavirus vaccine, according to researchers in the Institute for Biomedical Sciences at Georgia State University.

  • Drug delivery method can improve fungal infection treatment
    A unique method developed of drug delivery can prove useful to patients suffering from asthma, cystic fibrosis, or previous lung disease, human immunodeficiency virus HIV, cancer, or those exposed to corticosteroid medications for an extended duration.
Subscribe to Research News